ASCO GI 2023

Oesophageal and Gastric Cancer

Zolbetuximab plus mFOLFOX6 successful in CLDN18.2-positive subgroup of gastric cancer

Presented By

Dr Kohei Shitara, National Cancer Center Hospital East, Japan

Trial

Phase 3, SPOTLIGHT

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 08:31

Regorafenib offers survival benefit for patients with pre-treated gastric cancer

Presented By

Prof. Nick Pavlakis, University of Sydney, Australia

Trial

Phase 3, INTEGRATE IIa

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 08:24

Radiotherapy or not in locally advanced oesophageal or junctional cancer?

Presented By

Prof. Maeve Lowery, St James’s Hospital, Ireland

Trial

Phase 3, Neo-AEGIS

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 08:20

Neoadjuvant immunotherapy is safe and efficacious in a phase 2 gastric cancer trial

Presented By

Dr Filippo Pietrantonio, Fondazione IRCCS Istituto Nazionale dei Tumori, Italy

Trial

Phase 2, INFINITY

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 08:19

S-1 adjuvant chemotherapy: 4 or 8 courses in stage 2 gastric cancer?

Presented By

Dr Souya Nunobe, Cancer Institute Hospital, Japan

Trial

Phase 3, OPAS-1

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 08:18

LATG/LAPG demonstrates excellent long-term efficacy in stage 1 gastric cancer

Presented By

Dr Shinichi Sakuramoto, Saitama Medical University International Medical Center, Japan

Trial

JCOG1401

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 08:15

3-year follow-up data confirms benefits of nivolumab plus chemotherapy

Presented By

Dr Yelena Janjigian, Memorial Sloan Kettering Cancer, NY, USA

Trial

Phase 3, CheckMate 649

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 08:10

Long-term results for nivolumab plus chemotherapy and nivolumab plus ipilimumab in oesophageal cancer

Presented By

Dr Ken Kato, National Cancer Center Hospital, Japan

Trial

Phase 3, CheckMate 648

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 08:02

Promising phase 2 results for HER-Vaxx in gastric cancer

Presented By

Dr Tanuj Chawla, Tata Medical Center, India

Trial

Phase 2, HERIZON

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 08:00

Anal and Colorectal Cancer

IMbrave 151 missed primary endpoint in advanced BTC

Presented By

Prof. Anthony El-Khoueiry, USC Norris Comprehensive Cancer Center, CA, USA

Trial

Phase 2, IMbrave151

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 09:15

Combination botensilimab plus balstilimab demonstrates promising activity in heavily pre-treated MSS CRC

Presented By

Prof. Anthony El-Khoueiry, Norris Comprehensive Cancer Center, CA, USA

Trial

Phase 1, C-800

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 09:06

Mutation-based selection to identify patients suitable for panitumumab treatment

Presented By

Dr Kohei Shitara, National Cancer Center Hospital East, Japan

Trial

Phase 3, PARADIGM

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 09:01

Fucoidan associated with quality-of-life benefits in patients with rectal cancer receiving CCRT

Presented By

Prof. Jaw-Yuan Wang, Pingtung Hospital, Taiwan

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 08:58

ctDNA appears useful in monitoring patients with anal cancer undergoing CRT

Presented By

Dr Janet Alvarez, Memorial Sloan Kettering Cancer Center, NY, USA

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 08:55

SUNLIGHT trial meets primary endpoint in refractory metastatic CRC

Presented By

Prof. Josep Tabernero, Val d’Hebron University Hospital and Institute of Oncology, Spain

Trial

Phase 3, SUNLIGHT

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 08:45

Does cell-free DNA influence MRD testing in post-operative colon cancer?

Presented By

Dr Stacey Cohen, University of Washington, WA, USA

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 08:41

OPERA: surgery may be avoided with adequate therapy in rectal cancer

Presented By

Prof. Arthur Sun Myint, Clatterbridge Cancer Centre, UK

Trial

Phase 3, OPERA

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 08:39

Can we improve total neoadjuvant therapy for rectal cancer?

Presented By

Dr Thomas George, University of Florida, FL, USA

Trial

Phase 2, NRG-GI002

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 08:36

Hepatobiliary Cancer

Palliative radiation therapy improves hepatic pain in HCC and liver metastasis

Presented By

Prof. Laura Dawson, Princess Margaret Cancer Centre, Canada

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 09:30

Improved survival following postoperative sorafenib plus TACE in HCC

Presented By

Prof. Ming Kuang, The First Affiliated Hospital, China

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 09:28

Quality-of-life benefits for tislelizumab in uHCC

Presented By

Prof. Richard Finn, University of California Los Angeles, CA, USA

Trial

Phase 3, RATIONALE-301

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 09:26

Stereotactic body radiation therapy beneficial for patients with locally advanced HCC

Presented By

Prof. Laura Dawson, Princess Margaret Cancer Centre, Canada

Trial

Phase 3, NRG/RTOG1112

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 09:23

SWOG 1815, first-ever phase 3 trial in BTC, fails

Presented By

Prof. Rachna Shroff, University of Arizona Cancer Center, AZ, USA

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 09:20

Acceptable safety profile and encouraging efficacy of nanvuranlat in BTC

Presented By

Dr Junji Furuse, Kanagawa Cancer Center, Japan

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 09:11

Pancreatic Cancer

First-line NALIRIFOX superior to standard treatment in mPDAC

Presented By

Prof. Zev Wainberg, University of California Los Angeles, CA, USA

Trial

Phase 3, NAPOLI-3

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 09:37

Novel approach delivers quality-of-life benefits for patients with pancreatic cancer

Presented By

Dr Yaacov Lawrence, Sheba Medical Center, Israel

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 09:34